The knowns and unknowns of treatment for alcoholic hepatitis.

Sehrawat, Tejasav S; Liu, Mengfei; Shah, Vijay H

Sehrawat, Tejasav S; Liu, Mengfei; Shah, Vijay H.

Affiliation

Sehrawat TS; Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Liu M; Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Shah VH; Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA. Electronic address: shah.vijay@mayo.edu.

Lancet Gastroenterol Hepatol ; 5(5): 494-506, 2020 05.

Article in En | MEDLINE | ID: mdl-32277902

Subject(s)

Adrenal Cortex Hormones/therapeutic use; Alcoholism/therapy; Anti-Inflammatory Agents/therapeutic use; Hepatitis, Alcoholic/therapy; Alcohol Abstinence; Alcoholism/complications; Anti-Bacterial Agents/therapeutic use; Antioxidants/therapeutic use; Dietary Supplements; Hepatitis, Alcoholic/diagnosis; Hepatitis, Alcoholic/etiology; Humans; Pentanoic Acids/therapeutic use; Probiotics/therapeutic use; Receptors, Interleukin-1/antagonists & inhibitors; Signal Transduction; Tumor Necrosis Factor-alpha/antagonists & inhibitors

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adrenal Cortex Hormones / Alcoholism / Hepatitis, Alcoholic / Anti-Inflammatory Agents Type of study: Diagnostic_studies / Etiology_studies Limits: Humans Language: En Journal: Lancet Gastroenterol Hepatol Year: 2020 Document type: Article Affiliation country: United States Country of publication: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google